Market Cap (In CNY)
5.73 Billion
Revenue (In CNY)
3.58 Billion
Net Income (In CNY)
281.03 Million
Avg. Volume
2.66 Million
- Currency
- CNY
- Country
- Consumer Defensive
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 19.315384-35.48
- PE
- 16.17
- EPS
- 1.51
- Beta Value
- 0.896
- ISIN
- CNE100003NB0
- CUSIP
- -
- CIK
- -
- Shares
- 234679400.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- CEO
- Mr. Peiqing Li
- Employee Count
- -
- Website
- https://www.siriopharm.com
- Ipo Date
- 2019-09-25
- Details
- Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplements to customers worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; various nutraceutical gummies; probiotic products; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging. Sirio Pharma Co., Ltd. was founded in 1993 and is headquartered in Shantou, China.
More Stocks
-
NPR
-
PEY
-
CZNL
-
FKYS
-
0EWR
-
300815
-
000518
-
PVHPVH Corp.
PVH